NewsFeed Voices Science Insight Innovation
January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Ruben Mesa: Honored to Have Been The Senior Author of The Plenary Abstract of the Phase III SURPASS-ETs Trial at EHA25
Ruben Mesa/vjhemonc.com
Jun 16, 2025, 02:02

Ruben Mesa: Honored to Have Been The Senior Author of The Plenary Abstract of the Phase III SURPASS-ETs Trial at EHA25

Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, shared a post on LinkedIn:

“Honored to have been the senior author of this Plenary Abstract at EHA25 (presented by great colleague Harry Gill, The University of Hong Kong ) of the Phase III SURPASS ET trials showing Superiority of ROPEG over ANAGRELIDE in 2L for Essential Thrombocythemia”

Ruben Mesa: Honored to Have Been The Senior Author of The Plenary Abstract of the Phase III SURPASS-ETs Trial at EHA25

More posts featuring EHA 2025.

EHA 2025 EHA25 Hematology Hemostasis Today Ruben Mesa SURPASS-ETs Trial
NewsFeed